Analytical Data
-
Gene name
Milr1
- Application
-
Alternative Names
Allergy inhibitory receptor 1 Mast cell antigen 32 Short name: MCA-32 Short name: Mast cell Ag-32 Mast cell immunoglobulin-like receptor 1 Gm885, Mca32
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q3TB92
-
Expression Region
34-150aa
-
Molecular Weight
20.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Milr1, or the "myeloid immune-related receptor 1," is a protein that plays a crucial role in the immune response and is primarily expressed in myeloid cells. Research on Milr1 has gained traction due to its potential implications in various diseases, particularly in the context of cancer and autoimmune disorders. Understanding the structure and function of Milr1 as a recombinant protein can provide insights into its signaling pathways and interactions with other immune receptors. The development of Milr1 recombinant proteins allows researchers to investigate their biological activities, such as modulating immune responses or influencing cell differentiation. Additionally, studies have suggested that Milr1 may serve as a therapeutic target or biomarker in specific diseases, making it a focal point for both basic and applied research. As scientists explore the therapeutic potential of Milr1, the generation of high-purity recombinant proteins is critical for ensuring that subsequent functional assays yield reliable data. This research may pave the way for novel immunotherapeutic strategies aimed at enhancing the body's ability to fight malignancies or correct immune dysregulation.
